The cost of cancer in Europe 2018 T Hofmarcher, P Lindgren, N Wilking, B Jönsson European Journal of Cancer 129, 41-49, 2020 | 281 | 2020 |
The cost and burden of cancer in the European Union 1995–2014 B Jönsson, T Hofmarcher, P Lindgren, N Wilking European Journal of Cancer 66, 162-170, 2016 | 148 | 2016 |
The effect of education on poverty: A European perspective T Hofmarcher Economics of Education Review 83, 102124, 2021 | 98 | 2021 |
The societal costs of problem gambling in Sweden T Hofmarcher, U Romild, J Spångberg, U Persson, A Håkansson BMC public health 20, 1-14, 2020 | 61 | 2020 |
Comparator report on cancer in Europe 2019–disease burden, costs and access to medicines T Hofmarcher, G Brådvik, P Lindgren IHE-The Swedish Institute for Health Economics, 2019 | 57* | 2019 |
Comparator report on patient access to cancer medicines in Europe revisited B Jönsson, T Hofmarcher, P Lindgren, N Wilking | 41 | 2016 |
Cost-effectiveness analysis of ferric carboxymaltose in iron-deficient patients with chronic heart failure in Sweden T Hofmarcher, S Borg Journal of Medical Economics 18 (7), 492-501, 2015 | 34 | 2015 |
Cost effectiveness of implementing ESC guidelines for treatment of iron deficiency in heart failure in the Nordic countries T Hofmarcher, D Cabrales Alin, C Linde Scandinavian Cardiovascular Journal 52 (6), 348-355, 2018 | 13 | 2018 |
Access to high-quality oncology care across Europe T Hofmarcher, B Jönsson, N Wilking http://janssen-emea.com/sites/default/files/IHE_CC_Report_single_pages.pdf, 2014 | 13* | 2014 |
Specialization in same-sex and different-sex couples T Hofmarcher, E Plug Labour Economics 77, 101995, 2022 | 10 | 2022 |
The Porto European cancer research summit 2021 U Ringborg, A Berns, JE Celis, M Heitor, J Tabernero, J Schüz, ... Molecular oncology 15 (10), 2507-2543, 2021 | 9 | 2021 |
1588MO_PR A comparative study on costs of cancer and access to medicines in Europe N Wilking, G Brådvik, P Lindgren, C Svedman, B Jönsson, T Hofmarcher Annals of Oncology 31, S1197, 2020 | 8 | 2020 |
The cost of cancers of the digestive system in Europe T Hofmarcher, P Lindgren IHE Report 6, 2020 | 7 | 2020 |
The burden and direct cost of cancer in Europe (EU-28). NE Wilking, T Hofmarcher, P Lindgren, B Jönsson Journal of Clinical Oncology 34 (15_suppl), 6618-6618, 2016 | 7 | 2016 |
Systemic anti-cancer therapy patterns in advanced non-small cell lung cancer in Europe T Hofmarcher, P Lindgren, N Wilking Journal of Cancer Policy 34, 100362, 2022 | 6 | 2022 |
Diagnosed but not treated: How to improve patient access to advanced NSCLC treatment in Europe T Hofmarcher, P Lindgren, N Wilking IHE Report/IHE Rapport, 2022 | 6 | 2022 |
Cancer i Sverige–Hur mycket beror på påverkbara riskfaktorer? A Fridhammar, T Hofmarcher, S Persson IHE Report/IHE Rapport, 2020 | 6 | 2020 |
Cancer in Ireland–Disease Burden, Costs and Access to Medicines T Hofmarcher, O Ericson, P Lindgren IHE Report/IHE Rapport, 2022 | 4* | 2022 |
The effect of paid vacation on health: evidence from Sweden T Hofmarcher Journal of Population Economics 34 (3), 929-967, 2021 | 4 | 2021 |
Samhällets kostnader för spelproblem i Sverige T Hofmarcher, U Persson IHE Report/IHE Rapport, 2020 | 4 | 2020 |